Chicago, IL - A randomized, multicenter trial has added an uncertain piece to the puzzle of whether fatty acids from fish oil protect against ventricular arrhythmias, particularly in patients with ...
January 29, 2004 — Are the doldrums of winter bringing you down? Apparently, they may be doing more than just affecting the psyche. Dirk Müller, MD, Free University (Berlin, Germany), and colleagues ...
Limited information exists on whether ventricular tachycardia or fibrillation (VT/VF) affects the prognosis of patients undergoing percutaneous coronary intervention (PCI). After performing a ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
CHICAGO -- The angina drug ranolazine (Ranexa) did not help prevent ventricular arrhythmia events in high-risk implantable cardioverter-defibrillator (ICD) device patients in a randomized trial, but ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...
Pulseless ventricular tachycardia (VT) is an atypical heart rhythm that can cause chest pain, fainting, and cardiac arrest. Doctors treat it with cardiopulmonary resuscitation, defibrillators, and ...